Gastritis and Hearing loss
Summary:
Hearing loss is found among people with Gastritis, especially for people who are female, 60+ old.
The study analyzes which people have Hearing loss with Gastritis. It is created by eHealthMe based on reports of 56 people who have Gastritis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Gastritis?
Gastritis (inflammation of stomach) is found to be associated with 1,718 drugs and 1,916 conditions by eHealthMe. Check the latest studies of Gastritis.
What is Hearing loss?
Hearing loss is found to be associated with 1,358 drugs and 2,378 conditions by eHealthMe. Check the latest studies of Hearing loss.
56 people who have Gastritis and Hearing Loss are studied.

Gender of people who have Gastritis and experienced Hearing Loss *:
- female: 62.96 %
- male: 37.04 %
Age of people who have Gastritis and experienced Hearing Loss *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 4.08 %
- 40-49: 14.29 %
- 50-59: 20.41 %
- 60+: 61.22 %
Common co-existing conditions for these people *:
- High Blood Pressure: 21 people, 37.50%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 19 people, 33.93%
- Pain: 9 people, 16.07%
- High Blood Cholesterol: 9 people, 16.07%
- Insomnia (sleeplessness): 8 people, 14.29%
- Neuropathy Peripheral (surface nerve damage): 7 people, 12.50%
- Osteoporosis (bones weak and more likely to break): 7 people, 12.50%
- Nasopharyngitis (inflammation of the nasopharynx): 6 people, 10.71%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 10.71%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 5 people, 8.93%
Common drugs taken by these people *:
- Diovan: 9 people, 16.07%
- Lyrica: 8 people, 14.29%
- Voltaren: 8 people, 14.29%
- Humira: 7 people, 12.50%
- Omeprazole: 6 people, 10.71%
- Crestor: 5 people, 8.93%
- Omega 3: 4 people, 7.14%
- Pantoprazole: 4 people, 7.14%
- Paracetamol: 4 people, 7.14%
- Celebrex: 4 people, 7.14%
Common symptoms for these people *:
- Dizziness: 14 people, 25.00%
- Nausea (feeling of having an urge to vomit): 11 people, 19.64%
- Headache (pain in head): 10 people, 17.86%
- Cough: 9 people, 16.07%
- Tinnitus (a ringing in the ears): 9 people, 16.07%
- Pain In Extremity: 9 people, 16.07%
- Facial Paralysis (loss of function of face muscle): 8 people, 14.29%
- Nausea And Vomiting: 7 people, 12.50%
- Pain: 7 people, 12.50%
- Malaise (a feeling of general discomfort or uneasiness): 6 people, 10.71%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Hearing loss?
- Check whether Hearing loss is associated with a drug or a conditionRelated publications that referenced our studies
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Gastritis (55,650 reports)
- Hearing loss (30,352 reports)
All the drugs that are associated with Hearing loss:
- Hearing loss (1,358 drugs)
All the conditions that are associated with Hearing loss:
- Hearing loss (2,378 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Hearing loss and Gastritis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Benicar Hct cause Abnormal Loss Of Weight? - a second ago
- Could Ibrance cause Oropharyngeal Pain? - 2 seconds ago
- Could Rifampin cause Acute Hepatic Failure? - 2 seconds ago
- Could Bisoprolol Fumarate cause Colitis Microscopic? - 8 seconds ago
- Could Dupixent cause Oropharyngeal Pain? - 9 seconds ago
- Drug interactions of Toprol-Xl and Theophyl - 11 seconds ago
- Migraine and Oropharyngeal Pain - 12 seconds ago
- Ankylosing Spondylitis and Low Birth Weight Baby - 13 seconds ago
- Could Abilify cause Gastrointestinal Motility Disorder? - 18 seconds ago
- Drug interactions of Dulcolax and Glipizide - 21 seconds ago